Zonisamide Capsule
Product Images NDC 71335-2796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 71335-2796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 01)

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)
This text provides data on the improvement in seizures rate after treatment with Zonisamide capsules. It shows the percentage reduction in all partial seizures for a group of patients. The reduction rate is specified as 100% and 50% for different patients.*
FDA Label Image

Label (Lbl713352796)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.